توقعات سوق علاجات الميكروبيوم في أمريكا الشمالية حتى عام 2030 - التحليل الإقليمي - حسب النوع (العلاجات والإجراءات)، التطبيق (اضطراب التمثيل الغذائي والسمنة، عدوى المطثية العسيرة، مرض الأمعاء الالتهابي، وغيرها)، والمستخدم النهائي (المستشفيات والعيادات، الجراحة المتنقلة المراكز والرعاية المنزلية وغيرها)
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Microbiome Therapeutics Market Landscape
4.1 Overview
4.2 North America PEST Analysis
5. North America Microbiome Therapeutics Market - Key Industry Dynamics
5.1 North America Microbiome Therapeutics Market - Key Industry Dynamics
5.2 Key Market Drivers
5.2.1 Potential of Gut Microbiota in Maintaining Human Health
5.2.2 Inflow of Funds to Ameliorate Microbiome Discovery Pipeline
5.3 Key Market Restraints
5.3.1 High Cost of Development and Production
5.4 Key Market Opportunities
5.4.1 Increasing R&D to Gain Better Understanding of Human Microbiome
5.5 Key Future Trends
5.5.1 Technological Advancement in Human Microbiome Therapeutics
5.6 Impact of Drivers and Restraints:
6. Microbiome Therapeutics Market - North America Market Analysis
7. North America Microbiome Therapeutics Market Analysis - Type
7.1 Therapeutics
7.1.1 Overview
7.1.2 Therapeutics Market, Revenue and Forecast to 2030 (US$ Thousand)
7.2 Procedure
7.2.1 Overview
7.2.2 Procedure Market, Revenue and Forecast to 2030 (US$ Thousand)
8. North America Microbiome Therapeutics Market Analysis - Application
8.1 Metabolic Disorder and Obesity
8.1.1 Overview
8.1.2 Metabolic Disorder and Obesity Market, Revenue and Forecast to 2030 (US$ Thousand)
8.2 C. Difficile Infection (CDI)
8.2.1 Overview
8.2.2 C. Difficile Infection (CDI) Market, Revenue and Forecast to 2030 (US$ Thousand)
8.3 Inflammatory Bowel Disease
8.3.1 Overview
8.3.2 Inflammatory Bowel Disease Market, Revenue and Forecast to 2030 (US$ Thousand)
8.4 Others
8.4.1 Overview
8.4.2 Others Market, Revenue and Forecast to 2030 (US$ Thousand)
9. North America Microbiome Therapeutics Market Analysis - End User
9.1 Hospitals and Clinics
9.1.1 Overview
9.1.2 Hospitals and Clinics Market, Revenue and Forecast to 2030 (US$ Thousand)
9.2 Ambulatory Surgical Centers
9.2.1 Overview
9.2.2 Ambulatory Surgical Centers Market, Revenue and Forecast to 2030 (US$ Thousand)
9.3 Homecare
9.3.1 Overview
9.3.2 Homecare Market, Revenue and Forecast to 2030 (US$ Thousand)
9.4 Others
9.4.1 Overview
9.4.2 Others Market, Revenue and Forecast to 2030 (US$ Thousand)
10. North America Microbiome Therapeutics Market - Country Analysis
10.1 North America Microbiome Therapeutics Market Revenue and Forecasts and Analysis - By Country
10.1.1 North America Microbiome Therapeutics Market Revenue and Forecasts and Analysis - By Country
10.1.2 US
10.1.2.1 US: North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)
10.1.2.2 US: North America Microbiome Therapeutics Market Breakdown by Type
10.1.2.2.1 US North America Microbiome Therapeutics Market Breakdown by Therapeutics
10.1.2.3 US: North America Microbiome Therapeutics Market Breakdown by Application
10.1.2.4 US: North America Microbiome Therapeutics Market Breakdown by End User
10.1.3 Canada
10.1.3.1 Canada: North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)
10.1.3.2 Canada: North America Microbiome Therapeutics Market Breakdown by Type
10.1.3.2.1 Canada North America Microbiome Therapeutics Market Breakdown by Therapeutics
10.1.3.3 Canada: North America Microbiome Therapeutics Market Breakdown by Application
10.1.3.4 Canada: North America Microbiome Therapeutics Market Breakdown by End User
10.1.4 Mexico
10.1.4.1 Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)
10.1.4.2 Mexico: North America Microbiome Therapeutics Market Breakdown by Type
10.1.4.2.1 Mexico: North America Microbiome Therapeutics Market Breakdown by Therapeutics
10.1.4.3 Mexico: North America Microbiome Therapeutics Market Breakdown by Application
10.1.4.4 Mexico: North America Microbiome Therapeutics Market Breakdown by End User
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in North America Microbiome Therapeutics Market
12. Company Profiles
12.1 Ferring Holdings SA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Vedanta Biosciences Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Finch Therapeutics Group Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Pendulum Therapeutics Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Seres Therapeutics Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 AOBiome Therapeutics Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. North America Microbiome Therapeutics Market Segmentation
Table 2. North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousand) - Type
Table 3. North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousand) - Therapeutics
Table 4. North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousand) - Application
Table 5. North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousand) - End User
Table 6. North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Country
Table 7. US: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type
Table 8. US: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics
Table 9. US: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application
Table 10. US: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User
Table 11. Canada: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type
Table 12. Canada: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics
Table 13. Canada: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application
Table 14. Canada: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User
Table 15. Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type
Table 16. Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics
Table 17. Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application
Table 18. Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User
Table 19. Recent Growth Strategies in North America Microbiome Therapeutics Market
Table 20. Glossary of Terms, North America Microbiome Therapeutics Market
List of Figures
Figure 1. North America Microbiome Therapeutics Market Segmentation, By Country
Figure 2. North America PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Microbiome Therapeutics Market Revenue (US$ Thousand), 2022 - 2030
Figure 5. North America Microbiome Therapeutics Market Share (%) - Type, 2022 and 2030
Figure 6. Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousand)
Figure 7. Procedure Market Revenue and Forecasts to 2030 (US$ Thousand)
Figure 8. North America Microbiome Therapeutics Market Share (%) - Application, 2022 and 2030
Figure 9. Metabolic Disorder and Obesity Market Revenue and Forecasts to 2030 (US$ Thousand)
Figure 10. C. Difficile Infection (CDI) Market Revenue and Forecasts to 2030 (US$ Thousand)
Figure 11. Inflammatory Bowel Disease Market Revenue and Forecasts to 2030 (US$ Thousand)
Figure 12. Others Market Revenue and Forecasts to 2030 (US$ Thousand)
Figure 13. North America Microbiome Therapeutics Market Share (%) - End User, 2022 and 2030
Figure 14. Hospitals and Clinics Market Revenue and Forecasts to 2030 (US$ Thousand)
Figure 15. Ambulatory Surgical Centers Market Revenue and Forecasts to 2030 (US$ Thousand)
Figure 16. Homecare Market Revenue and Forecasts to 2030 (US$ Thousand)
Figure 17. Others Market Revenue and Forecasts to 2030 (US$ Thousand)
Figure 18. North America Microbiome Therapeutics Market Breakdown by Key Countries - Revenue (2022) (US$ Thousand)
Figure 19. North America Microbiome Therapeutics Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 20. US: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)
Figure 21. Canada: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)
Figure 22. Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)
1. AOBiome Therapeutics Inc
2. Ferring Holdings SA
3. Finch Therapeutics Group Inc
4. Pendulum Therapeutics Inc
5. Seres Therapeutics Inc